Preliminary report: Intracranial cholinergic drug infusion in patients with Alzheimer's disease

Keyphrases

• Alzheimer's Disease 100%
• Drug Infusion 100%
• Cholinergic Drugs 100%
• Cognitive Function 33%
• Subjective Response 33%
• Placebo 33%
• Toxicity Study 33%
• Cerebrospinal Fluid 33%
• Placebo-controlled 33%
• Feasibility Trial 33%
• Infusion System 33%
• Muscarinic Agonists 33%
• Potential Treatments 33%
• Social Function 33%
• Line Function 33%
• Totally Implantable 33%
• Bethanechol Chloride 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Cholinergic Receptor Stimulating Agent 100%
• Placebo 66%
• Base 33%
• Muscarinic Agent 33%
• Bethanechol 33%

Neuroscience

• Alzheimer's Disease 100%
• Parasympathomimetic Drug 100%
• Placebo 66%
• Bethanechol 33%
• Muscarinic Agonist 33%